SIPAI HEALTH: The trustee has purchased a total of 29.2802 million shares according to the 2023 stock incentive plan
思派健康公告称，受托人已根据 2023 年股份奖励计划购买 2928.02 万股股份，总代价约 1.95 亿港元，占已发行股份总数的 3.84%。该股份将用于奖励合资格参与者，以鼓励其为集团贡献。至今尚未授出任何股份。
智通财经 APP 讯，思派健康 (00314) 发布公告，公司获受托人告知，于本公告日期，受托人已于市场上购买合共 2928.02 万股股份，总代价为约 1.95 亿港元 (为免疑义，包括于 2023 年 10 月 31 日至 2024 年 1 月 18 日期间购买的 1271.52 万股股份)，占公司于本公告日期已发行股份总数约 3.84%。据此购买的股份将用作 2023 年股份奖励计划项下合资格参与者的奖励，以鼓励彼等为集团作出贡献。于本公告日期，公司尚未根据该计划授出任何股份。
Source: 智通财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments